Despite these promising results, the existence of heterogeneity in the CTC compartment has been demonstrated, as shown by Pestrin et al., who observed variability in the mutational status of the PIK3CA gene in breast cancer patients. This evidence concerns the gene PIK3CA and breast carcinoma.